This 2010 review by Rothman et al. explores the rationale and potential benefits of using combination pharmacotherapy for obesity treatment. Recognizing that appetite and weight regulation involve multiple physiological pathways, the authors argue that targeting several mechanisms simultaneously may enhance weight loss outcomes. They discuss various drug combinations, including phentermine/topiramate
